GLOBAL COMPLIANCE SEMINAR

Helping Industry Think and Execute Easier and Better

Biocompatibility

Use of ISO 10993-1 Within a Risk Management Process

FDA Recommendations on the Use of ISO 10993-1 within a Medical Device Risk Management Process The FDA issued the final guidance document Use of International Standard ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within

Jun

Mon

Jun

Tue

Jun

Fri

FDA Guidance on Expansion of the Abbreviated 510k Program
FDA Issued the Draft Guidance on the Expansion of the Abbreviated 510(k) Program Today, the United States Food and Drug Administration (FDA) has issued the (more…)
Completeness Assessments for Type II API DMFs Under GDUFA
FDA Guidance for the Industry Completeness Assessments for Type II API DMFs Under GDUFA By Global Compliance Seminar (LinkedIn; Twitter) This guidance is intended for holders of Type (more…)
Use of ISO 10993-1 for Medical Device Risk Management Process
FDA Guidance for Industry By Global Compliance Seminar (LinkedIn; Twitter) Use of International Standard ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within (more…)
FDA Data Integrity and Compliance with CGMP
FDA Guidance for the Industry By Global Compliance Seminar (LinkedIn; Twitter) Data Integrity and Compliance With CGMP The purpose of this guidance is to clarify the role of (more…)
ANDA Submissions-Content and Format
Guidance for Industry By Global Compliance Seminar (LinkedIn; Twitter) ANDA Submissions-Content and Format of Abbreviated New Drug Applications June 2014 Generics This guidance is intended to assist applicants (more…)